Kidney News and Research

RSS

Technique sheds new light on the processes involved in kidney stone formation

Up to 15% of people will experience kidney stones, and for 50% of those that do, they will recur. It is therefore important to understand as much as possible about how kidney stones form to improve both prevention and treatment.

26 Aug 2021

The influence of COVID-19 on platelet activation and aggregation

In a paper recently uploaded to the bioRxiv* preprint server, humanized ACE2 mice are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and platelets are subsequently isolated from the blood for quantitative proteomic analysis.

26 Aug 2021

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

26 Aug 2021

Less than 20% of patients with laboratory evidence of kidney disease are referred to nephrologists

Less than 20% of patients with laboratory evidence of kidney disease are referred for specialty care but most patients who are not referred have low predicted two-year risk of kidney failure.

25 Aug 2021

Higher mortality rates and age-related disease patterns in pediatric COVID-19

The current study examines children in pediatric ICU (PICU) care with COVID-19. Read more here.

25 Aug 2021

Number of adults with hypertension has doubled in the last thirty years

The number of adults aged 30–79 years with hypertension has increased from 650 million to 1.28 billion in the last thirty years, according to the first comprehensive global analysis of trends in hypertension prevalence, detection, treatment and control, led by Imperial College London and WHO, and published today in The Lancet.

25 Aug 2021

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments, and that fungi and bacteria have opposing effects on those responses.

24 Aug 2021

Study reveals trends in hypertension prevalence and progress in treatment over the past 30 years

Over the past 30 years, the number of adults (aged 30-79 years) living with hypertension worldwide has doubled—rising from an estimated 331 million women and 317 million men in 1990, to 626 million women and 652 million men in 2019, with most of this increase occurring in low- and middle-income countries (LMICs).

24 Aug 2021

COVID-19 with pre-eclampsia and acute fatty liver of pregnancy

A new study reports a case of pre-eclampsia complicated by the acute fatty liver of pregnancy (AFLP).

24 Aug 2021

Report reveals rising rates of diabetes among youth in the United States

Diagnosed cases of type 1 and type 2 diabetes are surging among youth in the United States. From 2001 to 2017, the number of people under age 20 living with type 1 diabetes increased by 45%, and the number living with type 2 diabetes grew by 95%.

24 Aug 2021

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

A new clinical trial to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems is launching in the UK.

24 Aug 2021

Maintaining good hydration throughout life may reduce the risk of heart failure

Staying well hydrated throughout life could reduce the risk of developing heart failure, according to research presented at ESC Congress 2021.

24 Aug 2021

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

24 Aug 2021

SARS-CoV-2 Delta variant associated with more breakthrough infections

The study highlights that compared to the previously circulating alpha variant, the delta variant is associated with higher infectious virus load and a lower level of humoral immunity in the upper respiratory tract. The study is currently available on the medRxiv* preprint server prior to peer review.

24 Aug 2021

Researchers develop brain organoids that show neural activity similar to living human brains

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed brain organoids - 3D, brain-like structures grown from human stem cells - that show organized waves of activity similar to those found in living human brains.

24 Aug 2021

As temperatures rise, so do the health risks for California’s farmworkers

Leoncio Antonio Trejo Galdamez, 58, died in his son's arms on June 29 after spending the day laying irrigation pipes in California's Coachella Valley. News of his death reverberated through the largely Latino community near the Mexican and Arizona borders — another casualty in a dangerous business.

23 Aug 2021

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Extreme heat is an increasingly common occurrence worldwide, with heat-related deaths and illnesses also expected to rise.

20 Aug 2021

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests

Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

19 Aug 2021

Cancer linked with increased risk of kidney failure

Previous studies have shown an increased cancer risk within the dialysis and kidney transplant populations compared to the general population. However, it is unclear whether cancer increases the risk of kidney failure.

18 Aug 2021

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

As COVID-19 cases rise due to the Delta variant, the Centers for Disease Control (CDC) has approved third dose vaccinations for patients whose immune systems are compromised moderately to severely.

17 Aug 2021

Kidney News and Research

Technique sheds new light on the processes involved in kidney stone formation

The influence of COVID-19 on platelet activation and aggregation

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Less than 20% of patients with laboratory evidence of kidney disease are referred to nephrologists

Higher mortality rates and age-related disease patterns in pediatric COVID-19

Number of adults with hypertension has doubled in the last thirty years

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Study reveals trends in hypertension prevalence and progress in treatment over the past 30 years

COVID-19 with pre-eclampsia and acute fatty liver of pregnancy

Report reveals rising rates of diabetes among youth in the United States

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

Maintaining good hydration throughout life may reduce the risk of heart failure

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

SARS-CoV-2 Delta variant associated with more breakthrough infections

Researchers develop brain organoids that show neural activity similar to living human brains

As temperatures rise, so do the health risks for California’s farmworkers

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests

Cancer linked with increased risk of kidney failure

UC Davis Health offers third dose COVID-19 'booster' shots to immunocompromised patients

Event guide: 8th CKD Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News